Respiri grows wheezo market potential through agreement with the Pharmacy Guild of Australia

Respiri’s agreement with the Pharmacy Guild of Australia will build awareness and knowledge of its wheeze respiratory evaluation device and technology. Respiri has already secured telehealth partnerships with Phenix Health and Practice Innovators to grow use and awareness of the technology throughout Australia. For the full article please visit: https://smallcaps.com.au/respiri-wheezo-market-agreement-pharmacy-guild-of-australia/

Shareholders back Respiri in heavily oversubscribed share purchase plan

Wheezo asthma diagnostic and monitoring technology Respiri has developed its wheezo device and eHealth software as a service technology to support the management of respiratory health. Machine learning is employed to detect wheeze via the wheezo device and app. Wheeze is a typical asthma symptom and is common in other respiratory disorders. The technology is […]